Last reviewed · How we verify
Qinggongshoutao Bolus
Qinggongshoutao Bolus is a Small molecule drug developed by Dongzhimen Hospital, Beijing. It is currently FDA-approved. Also known as: Ginkgo biloba also named Egb761 or Ginaton.
At a glance
| Generic name | Qinggongshoutao Bolus |
|---|---|
| Also known as | Ginkgo biloba also named Egb761 or Ginaton |
| Sponsor | Dongzhimen Hospital, Beijing |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Qinggongshoutao Bolus CI brief — competitive landscape report
- Qinggongshoutao Bolus updates RSS · CI watch RSS
- Dongzhimen Hospital, Beijing portfolio CI
Frequently asked questions about Qinggongshoutao Bolus
What is Qinggongshoutao Bolus?
Qinggongshoutao Bolus is a Small molecule drug developed by Dongzhimen Hospital, Beijing.
Who makes Qinggongshoutao Bolus?
Qinggongshoutao Bolus is developed and marketed by Dongzhimen Hospital, Beijing (see full Dongzhimen Hospital, Beijing pipeline at /company/dongzhimen-hospital-beijing).
Is Qinggongshoutao Bolus also known as anything else?
Qinggongshoutao Bolus is also known as Ginkgo biloba also named Egb761 or Ginaton.
What development phase is Qinggongshoutao Bolus in?
Qinggongshoutao Bolus is FDA-approved (marketed).
Related
- Manufacturer: Dongzhimen Hospital, Beijing — full pipeline
- Also known as: Ginkgo biloba also named Egb761 or Ginaton
- Compare: Qinggongshoutao Bolus vs similar drugs
- Pricing: Qinggongshoutao Bolus cost, discount & access